Filing Details
- Accession Number:
- 0001562180-17-001257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-14 16:43:07
- Reporting Period:
- 2017-03-10
- Filing Date:
- 2017-03-14
- Accepted Time:
- 2017-03-14 16:43:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 902080 | C Roger Lucas | 41 East Pleasant Lake Road North Oaks MN 55127 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-10 | 79 | $107.76 | 3,650 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-03-10 | 21 | $107.81 | 3,629 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $101.19 | 2026-10-26 | 3,985 | 3,985 | Direct | |
| Common Stock | Stock Option (right to buy) | $91.78 | 2014-10-30 | 2024-10-30 | 4,000 | 4,000 | Direct |
| Common Stock | Stock Option (right to buy) | $87.39 | 2013-10-31 | 2023-10-30 | 4,000 | 4,000 | Direct |
| Common Stock | Stock Option (right to buy) | $87.34 | 2016-10-29 | 2025-10-28 | 4,260 | 4,260 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-10-26 | 3,985 | 3,985 | Direct |
| 2024-10-30 | 4,000 | 4,000 | Direct |
| 2023-10-30 | 4,000 | 4,000 | Direct |
| 2025-10-28 | 4,260 | 4,260 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016.
- The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.
Billionaire Hedge Funds
